#AceNewsServices – UNITED STATES – September 17 – This is post from a fellow blogger and writer David Hodge and this a snippet from his article – source link to more at the bottom of this post:
Nothing changed just as he wrote it but no surprise for me! He wrote as follows:
The seed money began at $1.5 million. The value of the deal could grow to an estimated $86 million dollars.
The company’s name is Tekmira Pharmaceuticals Corporation (TKMR) (TKM.TO), a leading developer of RNA interference (RNAi) therapeutics. “TKM-Ebola, an anti-Ebola virus RNAi therapeutic, is being developed under a $140 million contract with the U.S. Department of Defence’s Medical Countermeasure Systems BioDefense Therapeutics (MCS-BDTX) Joint Product Management Office”.
As breaking and shocking of a news story as this has the potential to be, the real story is that this is not the most important part of the Ebola threat which has invaded the United States. The truth of the matter is that these unholy and untrustworthy associations, when it comes to “fighting” the Ebola virus, represent the mere tip of the iceberg.